All
A Christmas Carol: Lessons Learned From the Past, Present and Future
Watching "Scrooge" every Christmas made me reflect on my own journey, where my past struggles with illness taught me valuable lessons about forgiveness, love and joy.
Top FDA Approvals of Oncology Therapies in 2024
As we near the end of 2024, CURE is looking back at the top FDA approval stories of the year.
Epkinly Leads to Responses in Heavily Pretreated Patients With CLL
Among patients with heavily pretreated chronic lymphocytic leukemia, treatment with Epkinly monotherapy showed deep responses.
Recognizing Excellence in Oncology Nursing
An oncology nurse demonstrated care not only to her patients with cancer but also to her own staff.
FDA Grants Jemperli Breakthrough Therapy Designation in dMMR/MSI-H Rectal Cancer
Jemperli received breakthrough therapy designation by the FDA for locally advanced mismatch repair deficient/microsatellite instability-high rectal cancer.
Darzalex Regimen May Improve MRD Responses in Multiple Myeloma
Patients newly diagnosed with multiple myeloma who are transplant ineligible or deferred may benefit from receiving a Darzalex treatment combination.
How to Self Advocate When Insurance Says No to Cancer Treatment Coverage
When insurance denies coverage of cancer treatment, patients with cancer don’t need to take no for an answer, an expert explained.
FDA Approves Braftovi Plus Erbitux and Chemo for Metastatic Colorectal Cancer Subset
Braftovi received accelerated approval with Erbitux and mFOLFOX6 for metastatic colorectal cancer with a BRAF V600E mutation.
Reflecting on Cancer During a Christmas Morning Run
A reflective Christmas morning run, following a cancer diagnosis, inspires profound gratitude for life and a renewed commitment to living a meaningful life.
NFL Star Randy Moss Undergoing Cancer Treatment, Montell Jordan Shares Update and More
From a Pro Football Hall of Famer announcing his diagnosis to an R&B star’s latest update, here’s what’s happening in the cancer space this week.
Zejula-Jemperli Combo Shows Promising Responses in Breast Cancer Subset
A combination of presurgical Zejula and Jemperli showed promising treatment responses in certain patients with ER-positive, HER2-negative breast cancer.
Enhertu May Help Preserve Quality of Life in HER2-Positive Breast Cancer
Treatment with Enhertu showed favorable outcomes regarding health-related quality of life in patients with HER2-positive breast cancer, regardless of brain metastases.
Targeting Multiple Pathways Improves Outcomes in Some With Metastatic Breast Cancer
Targeting the estrogen receptor and HER2 pathways improved progression-free survival in patients with HR-positive, HER2-positive metastatic breast cancer.
Embracing Gratitude During the Holidays
A survivor shares tips on ways to practice gratitude the holiday season.
UGN-102 May Improve Quality of Life Versus Surgery in Bladder Cancer
Treatment with UGN-102 has shown promise as a non-surgical alternative when compared with a surgical approach for certain patients with bladder cancer.
What is Follicular Lymphoma and Why Are Better Treatments Needed?
CURE® spoke with an expert about follicular lymphoma, a disease that is still considered incurable.
Ryoncil Receives FDA Approval for Children With GVHD
This marks the first mesenchymal stromal cell therapy approved by the FDA for children with acute graft versus host disease.
FDA Approves Ensacove for ALK-Positive NSCLC
The Food and Drug Administration has approved Ensacove for patients with ALK-positive locally advanced or metastatic non-small cell lung cancer who have not previously received an ALK-inhibitor.
How to Get the Most from Patient Portals During a Cancer Journey
An expert advises a few things to keep in mind when patients with cancer are navigating these platforms.
A Holiday Poem: Who Says Cancer Doesn’t Rhyme?
The holiday season is here, so here’s a festive poem to remind us that cancer should not control us during this time.
Understanding Prostate Cancer Treatment Side Effects Is Key
A study showed that patients with prostate cancer should consider the long-term side effects of treatments before deciding on the appropriate options.
Imbruvica-Venetoclax Shows Promise in Managing CLL
A combination of Imbruvica and venetoclax showed significantly prolonged progression-free survival in patients with untreated CLL, an expert explained.
Surgical Intervention May Improve Survival in Young Patients with Breast Cancer
Younger patients with breast cancer and the BRCA gene showed improved survival after undergoing risk-reducing mastectomy and/or risk-reducing salpingo-oophorectomy.
Why Cancer Caregivers Need to Avoid Burnout
An expert explained the impact that burnout can have on someone caring for a loved one with cancer.
You’re ‘Just Human’: When Cancer Caregivers Need to Ask for Help
Caregivers shouldn’t hesitate to ask for help when it comes to coordinating care for a loved one.
Resources Available for Cancer Caregivers
From counseling services to wellness workshops, there is a wide array of resources potentially available to caregivers, as an expert explained.
How Communication Gaps Can Affect Caregivers and Patients
An expert explained that improved communication will make caregivers of loved ones with cancer feel less isolated.
Keeping Cancer Out of the Closet
I’m very grateful for my SLL medication, but I never thought a side effect of the medication would affect my wardrobe for the rest of my life.
Black Patients With Myeloma Face Taste, Skin Side Effects from Talvey
Black patients may be more affected by certain side effects from Talvey compared with White patients with multiple myeloma, an expert told CURE®.
2025 Medicare Changes ‘Much Simpler’ for Eligible Patients With Cancer
With a significant change happening in the Medicare space in early 2025, patients with cancer eligible for Medicare may see its benefits soon.